Panminerva Med. 2024 Jun;66(2):188-197. doi: 10.23736/S0031-0808.23.05047-4. Epub 2023 Dec 21.
PMID:38127062
Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S, Fukumoto S, Xia W, Corsi A, Colangelo L, Scillitani A, Pepe J, Cipriani C, Thakker RV.
Endocr Rev. 2023 Mar 4;44(2):323-353. doi: 10.1210/endrev/bnac026.
PMID:36327295
Tumor-induced osteomalacia: An overview.
Jadhav SS, Shah R, Patil V.
Best Pract Res Clin Endocrinol Metab. 2024 Mar;38(2):101834. doi: 10.1016/j.beem.2023.101834. Epub 2023 Oct 20.
PMID:37935612
Tumor-induced osteomalacia.
Yin Z, Du J, Yu F, Xia W.
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
PMID:30775554
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO.
J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12.
PMID:33338281
Tumor-induced osteomalacia.
Aoyama N, Nishiyama M, Namba H, Ikeuchi M, Fujimoto S, Terada Y.
QJM. 2023 Feb 14;116(1):78-79. doi: 10.1093/qjmed/hcac219.
PMID:36066446
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S.